Prescribing patterns and pharmacoeconomic analysis of antihypertensive drugs in South Indian population: A cross-sectional study

Prescribing patterns and pharmacoeconomic analysis of antihypertensive drugs in South Indian population: A cross-sectional study

Background: Global evidence-based recommendations for hypertension management are periodically updated, and ensuring adherence to the guidelines is imperative. Furthermore, the current high prevalence of hypertension effectuates a high health-care cost. Purpose: To evaluate the prescribing patterns...

Full description

Bibliographic Details
Main Authors:	S Shanmugapriya, Saravanan Thangavelu, Aashiq Ahamed Shukkoor, P Janani, R Monisha, Varsha Elsa Scaria
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2023-01-01
Series:	Perspectives in Clinical Research
Subjects:	antihypertensive treatment hypertension pharmacoeconomic analysis prescribing pattern target blood pressure
Online Access:	http://www.picronline.org/article.asp?issn=2229-3485;year=2023;volume=14;issue=3;spage=114;epage=122;aulast=Shanmugapriya

Similar Items

PHARMACOEPIDEMIOLOGICAL AND PHARMACOECONOMIC STUDIES OF ANTIHYPERTENSIVE TREATMENT IN RUSSIA. Analytical Review
by: T. S. Romanenko, et al.
Published: (2015-09-01)

PHARMACOECONOMIC ANALYSIS OF ANTIHYPERTENSIVE DRUG COMBINATIONS USE
by: E. I. Tarlovskaya, et al.
Published: (2015-09-01)

Prescribing Patterns of Antihypertensive Medications in US Ambulatory Care Settings
by: Yelena Sahakian, et al.
Published: (2019-06-01)

Prescribing patterns of antihypertensive medications: A systematic review of literature between 2010 and 2020
by: Nada Nabil Abdelkader, et al.
Published: (2023-09-01)

Pharmacoeconomic study of the treatment of arterial hypertension in children and adolescents using cost-of-illness analysis
by: O. S. Mikhaylova, et al.
Published: (2022-07-01)

Outpatient antihypertensive drug utilization in Canton Sarajevo during five years period (2004-2008) and adherence to treatment guidelines assessment
by: Tarik Čatić, et al.
Published: (2011-05-01)

Pharmacoeconomic analysis in various nosologies
by: A. A. Svistunov, et al.
Published: (2022-12-01)

CURRENT TARGET OF ANTIHYPERTENSIVE THERAPY. DATA FROM CLINICAL TRIALS. PART 2
by: V. V. Popov, et al.
Published: (2015-12-01)

CURRENT TARGET OF ANTIHYPERTENSIVE THERAPY. DATA FROM CLINICAL TRIALS. PART 1
by: V. V. Popov, et al.
Published: (2015-12-01)

Pharmacoeconomic evaluation of the use of targeted therapy and chemotherapy in the first- and second-line therapies for metastatic colorectal cancer
by: A. A. Tryakin, et al.
Published: (2018-11-01)

Pharmacoeconomic effectiveness of phytotherapy in complex treatment of pyelonephritis
by: V. V. Ivanov, et al.
Published: (2015-04-01)

Current Situation and Prospect of Pharmacoeconomic Evaluation of Hemophilia in China
by: LI Shunping, et al.
Published: (2022-10-01)

THE FEATURES OF METHODOLOGY FOR PHARMACOECONOMICS ANALYSIS OF VACCINATION
by: A. Yu. Kulikov, et al.
Published: (2015-03-01)

What drugs do hypertension patients take in clinical practice? Structure of antihypertensive drugs in a large siberian region
by: Y. I. Grinshtein, et al.
Published: (2016-12-01)

The pharmacoeconomic efficacy of chemotherapy for malignant neoplasms of the bronchus and lung
by: S. K. Yarovoy, et al.
Published: (2020-04-01)

Lipid Profile and Antihypertensive Drugs
by: Abdul-Khader A. Abdul-Khader
Published: (2009-06-01)

Current prescription status of antihypertensive drugs in Chinese patients with hypertension: analysis by type of comorbidities
by: Renren Yang, et al.
Published: (2022-04-01)

COMBINED ANTIHYPERTENSIVE THERAPY IN REAL CLINICAL PRACTICE. FOCUS ON FIXED COMBINATIONS OF ANTIHYPERTENSIVE DRUGS (According to the Data of Outpatient Registries RECVASA and PROFILE)
by: S. Yu. Martsevich, et al.
Published: (2017-07-01)

Analysis of prescription status of antihypertensive drugs in Chinese patients with hypertension based on real-world study
by: Renren Yang, et al.
Published: (2023-12-01)

PHARMACOECONOMIC ANALYSIS OF OLMESARTAN THERAPY IN THE INDIVIDUAL–LEVEL MANAGEMENT OF ARTERIAL HYPERTENSION
by: S. G. Gorokhova, et al.
Published: (2012-08-01)

DANGER OF ALCOHOL FOR PATIENTS WITH ARTERIAL HYPERTENSION DURING ANTIHYPERTENSIVE THERAPY
by: M. P. Savenkov, et al.
Published: (2016-01-01)

Withdrawal of antihypertensive medication in young to middle-aged adults: a prospective, single-group, intervention study
by: Hae-Young Lee, et al.
Published: (2023-01-01)

PHARMACOECONOMIC ANALYSIS OF CARVEDILOL THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION AND METABOLIC RISK FACTORS (ACCORDING TO THE CAMELLIA STUDY)
by: S. Y. Martsevich, et al.
Published: (2016-01-01)

Pharmacoeconomics in Africa: needs, prospect and challenges
by: Temitope Ben-Ajepe, et al.
Published: (2021-12-01)

Resistance to antihypertensive treatment and long‐term risk: The Atherosclerosis Risk in Communities study
by: Magnus O. Wijkman, et al.
Published: (2021-10-01)

Development conceptual of pharmacoeconomic model of technology for early diagnosis and pharmacotherapy of pulmonary arterial hypertension
by: I. S. Datsenko
Published: (2022-12-01)

SEARCH FOR UNIVERSAL COMBINED ANTIHYPERTENSIVE THERAPY WITHIN LIMITED DATA ON THE COMPARATIVE EFFICACY OF ANTIHYPERTENSIVE AGENTS
by: S. R. Gilyarevskiy
Published: (2015-09-01)

INNOVATIVE ANTIHYPERTENSIVE THERAPY IN THE LIGHT OF COMPLETED CLINICAL TRIALS
by: N. A. Nikolaev
Published: (2016-01-01)

Correlation between Degree of Compliance to Antihypertensives with Severity of Stroke
by: Hirra Mumtaz, et al.
Published: (2018-09-01)

Scientific substantiation of the concept of pharmacoeconomic analysis of technologies for early diagnosis and pharmacotherapy of pulmonary arterial hypertension
by: I. S. Datsenko, et al.
Published: (2022-10-01)

USE OF URAPIDIL - ANTIHYPERTENSIVE DRUG WITH DOUBLE ACTION - NEW DIRECTION IN TREATMENT OF HYPERTENSIVE CRISES
by: V. R. Abdrakhmanov, et al.
Published: (2015-09-01)

Difference in Antihypertensive Medication Pattern in the First Year Compared to More than a Year of Maintenance Hemodialysis: A Northern India Tertiary Care Experience
by: Abhilash Chandra, et al.
Published: (2022-07-01)

HYPERVISCOSITY SYNDROME IN ARTERIAL HYPERTENSION AND HEMORHEOLOGICAL EFFECTS OF ANTIHYPERTENSIVE DRUGS
by: A. Yu. Shamanaev, et al.
Published: (2016-04-01)

Antihypertensive drug reduction for treated hypertensive patients during the summer
by: Kimika Arakawa, et al.
Published: (2019-05-01)

Pharmacoeconomic aspects of COVID-19 treatment
by: I. V. Rogova, et al.
Published: (2021-10-01)

PHARMACOECONOMIC STUDY OF SKIN TESTS IN THE DIAGNOSTICS OF TUBERCULOSIS INFECTION
by: R. I. Yagudina, et al.
Published: (2015-03-01)

MODERN OPPORTUNITIES FOR ANTIHYPERTENSION THERAPY: THE PLACE OF AZILSARTAN MEDOXOMIL
by: V. V. Skibitsky, et al.
Published: (2017-12-01)

PHARMACOECONOMICS OF APPLICATION OF HEPATOPROTECTORS IN THERAPY OF DRUG-INDUCED LIVER INJURY AFTER CHEMOTHERAPY
by: D. D. Morikov, et al.
Published: (2017-04-01)

Trends in Antihypertensive Medicine Utilization in the Republic of Srpska, Bosnia and Herzegovina: An Eleven-Year Follow-Up
by: Dragan Kalinić, et al.
Published: (2022-06-01)

Initial antihypertensive therapy: Prescription pattern at the outpatient cardiology clinic of University of Nigeria teaching hospital, Enugu
by: S O Ike, et al.
Published: (2006-01-01)